|
491 |
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient Enthalten in Oncology Bd. 104, 2026, Nr. 1: 79-91. 13 S.
|
|
|
492 |
Variations in Characteristics and Clinical Outcomes of Esophageal Squamous Cell Carcinoma among Asian American Enthalten in Oncology Bd. 104, 2026, Nr. 1: 51-62. 12 S.
|
|
|
493 |
ISPAD Position Statement on Type 1 Diabetes in Schools Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 147-157. 11 S.
|
|
|
494 |
Variability in Body Mass Index during 2018–2021 for People with Type 1 Diabetes: Real World Data from the USA, Germany, and Australasia Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 138-146. 9 S.
|
|
|
495 |
Phase 2 Trial of Vosoritide Use in Patients with Hypochondroplasia: A Pharmacokinetic/Pharmacodynamic Analysis Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 131-137. 7 S.
|
|
|
496 |
Strategies for Equitable Recruitment to Engage Underrepresented Youth and Their Families into Clinical Research: Findings from the BEAD-T1D Pilot Study Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 122-130. 9 S.
|
|
|
497 |
Ketone Management in Pediatric Diabetes Centers in the USA: Current Practices and a Call for Improved Standardization Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 113-121. 9 S.
|
|
|
498 |
Obesity Is Associated with Increased 11-Oxyandrogen Serum Concentrations during Puberty Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 91-100. 10 S.
|
|
|
499 |
Defining Success in the Delivery of Fertility-Related Care for Patients with Differences of Sex Development Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 81-90. 10 S.
|
|
|
500 |
Thyrotoxic Hypokalemic Periodic Paralysis Induced by High-Dose Insulin in an Adolescent Male with Type 1 Diabetes Mellitus Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 57-61. 5 S.
|
|